by Eric Christianson | Apr 29, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Clonidine and guanfacine are both alpha-2 adrenergic agonists used in the treatment of ADHD, but they behave differently enough in clinical practice that they are not truly interchangeable. In this article, we will compare and contrast clonidine versus guanfacine in...
by Eric Christianson | Apr 26, 2026 | Polypharmacy Cases And The Prescribing Cascade
As-needed medications (PRNs) are a common part of life for geriatric patients in long-term care and assisted living facilities. They can make things more complicated as well, and I would implore you to review these medications frequently to ensure that they are truly...
by Eric Christianson | Apr 22, 2026 | Gastrointestinal Case Studies
One of the most common (and easily fixable) medication mismatches I see in practice involves bowel regimens that outlive their original purpose. This is a great example of how deprescribing can reduce pill burden and prevent unnecessary adverse effects. Bowel Regimens...
by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | Apr 15, 2026 | Hematology and Immunology Medication and Disease State Clinical Pearls
Epoetin alfa (Epogen/Procrit) is a medication pharmacists commonly encounter in long-term care, dialysis, and oncology settings. While its role in stimulating red blood cell production seems straightforward, there are several key clinical pearls that are essential to...
